Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- RH shares plunge after the home furnishing company forecast revenue for the first quarter that missed the average analyst estimate.
- Beyond Meat (BYND) forecast net revenue for the first quarter; the guidance missed the average analyst estimate.
- Tilray Brands (TLRY) reaffirmed its adjusted Ebitda guidance for the full year; the guidance beat the average analyst estimate.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Nike (NKE) shares tumbled after the retailer gave a surprisingly gloomy outlook for the year ahead, complicating Chief Executive Officer Elliott Hill’s efforts to turn around the business. Revenue is expected to decline 2% to 4% in the current quarter and will be down in the low single-digits for the rest of the calendar year, management told investors on an earnings call Tuesday evening. Analysts surveyed by Bloomberg had been looking for 2% sales growth this quarter and bigger gains as the year progressed.
- RH shares plunge after the upscale furnishing company forecast revenue for the first quarter that missed the average analyst estimate. Analysts say the forecast is pressured by execution and supply chain disruptions.
- Walt Disney (DIS) shares rises as Raymond James upgrades to outperform from market perform, citing an attractive entry point for the stock.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Rolls-Royce shares jump as much as 10%, the biggest gain in eight months.
- Lufthansa is readying plans to ground planes in case demand drops because of the war in the Middle East. Europe’s biggest aviation group has assigned teams to develop crisis responses that differ in severity, Chief Executive Officer Carsten Spohr told employees Tuesday, according to a spokesman for Lufthansa.
- Berkeley shares plunged the most in almost 10 years after the UK housebuilder signaled smaller-than-anticipated earnings in the medium term, citing reduced potential for interest rate cuts on account of the Iran War.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Shell shares dip as much 2.4% amidst uncertainty in energy markets tied to the Middle East conflict.
- Lufthansa is readying plans to ground planes in case demand drops because of the war in the Middle East. Europe’s biggest aviation group has assigned teams to develop crisis responses that differ in severity, Chief Executive Officer Carsten Spohr told employees Tuesday, according to a spokesman for Lufthansa.
- Berkeley shares plunged the most in almost 10 years after the UK housebuilder signaled smaller-than-anticipated earnings in the medium term, citing reduced potential for interest rate cuts on account of the Iran War.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Nike (NKE) shares slipped despite reporting better-than-expected sales on concerns that the war in Iran could exacerbate weakness in the region that includes Europe and the Middle East and disrupt the sportswear company’s turnaround. Sales were $11.3 billion in the company’s fiscal third quarter, surpassing the average of estimates compiled by Bloomberg but flat from a year earlier. While performance in China improved, the Converse brand remained a problem area and the EMEA region, which also includes Africa, missed estimates.

- Airlines climb as much as: United +8.6%, Delta +6.7%, American +6.1%. The S&P Supercomposite Airlines Industry Index jumps as much as 6.6%, the most since Feb. 6. Jet fuel prices have soared during the war, prompting warnings from across Wall Street about the financial impact on carriers and pushing the airlines index into a bear market

- Biogen has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments in immunology and rare diseases in one of the company’s largest-ever acquisitions.The Cambridge, Massachusetts-based biotech company will pay $41 a share for Apellis, more than double its closing price on Monday, Biogen said in a statement, confirming a Bloomberg News report. Apellis’ (APLS) stock had declined 32% so far this year through Monday’s close. Apellis shares soared 135% to $40.23 on Tuesday in New York, their largest jump ever. Biogen shares closed down 2.3%.
See omnystudio.com/listener for privacy information.